Skip to main content
Gufic BioSciences Ltd. logo

Gufic BioSciences Ltd. — Investor Relations & Filings

Ticker · GUFICBIO ISIN · INE742B01025 LEI · 3358003C6YDH6EIDBP63 BSE.NS Manufacturing
Open in API
Filings indexed 1,192 across all filing types
Latest filing 2025-09-30 Regulatory Filings
Country IN India
Listing BSE.NS GUFICBIO

About Gufic BioSciences Ltd.

https://gufic.com/

Gufic BioSciences Ltd. focuses on the research, development, and large-scale manufacturing of pharmaceutical formulations and active pharmaceutical ingredients. The organization is distinguished by its specialized expertise in lyophilization technology, operating extensive facilities for the production of freeze-dried injectables. Its product portfolio encompasses a wide range of therapeutic areas, including critical care, infertility, oncology, and gastroenterology. In addition to conventional medicine, the company develops proprietary herbal and ayurvedic formulations through integrated scientific research. Gufic emphasizes advanced drug delivery systems and maintains a significant presence in the production of antibiotics, antifungal agents, and cardiac medications. The company serves a global clientele by providing high-quality generic and specialty healthcare solutions.

Recent filings

Filing Released Lang Actions
Voting Results and Consolidated Scrutinizer Report of 41st Annual General Meeting of the Company held on Monday, September 29, 2025 is attached herewith
Regulatory Filings
2025-09-30 English
Shareholders meeting
Regulatory Filings
2025-09-30 English
Proceedings of the 41st Annual General Meeting of the Company held on Monday, September 29, 2025 is attached herewith.
AGM Information Classification · 95% confidence The document is titled 'Proceedings of the 41st Annual General Meeting' and details the conduct and discussions of the AGM held on September 29, 2025. It includes information about the meeting format (VC/OAVM), attendance, agenda items, voting procedures, and resolutions passed. It references the Annual Report and Auditor's report but does not contain the full financial statements or detailed financial data itself. The document is a detailed record of the AGM proceedings rather than the Annual Report or any other financial report. Therefore, it fits the category of AGM Information (AGM-R). The document length (10,347 characters) supports that it is a substantive report of the meeting proceedings, not a brief announcement or certification.
2025-09-29 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is titled 'Proceedings of the 41st Annual General Meeting' and details the conduct and discussions of the AGM held on September 29, 2025. It includes information about the meeting format (VC/OAVM), attendance, voting procedures, resolutions considered, and statements by the Chairman and other executives. It references the Annual Report and Auditor's report but does not contain the full financial statements or detailed financial data itself. The document is a detailed record of the AGM proceedings rather than the Annual Report or any other financial report. Therefore, it fits the category of AGM Information (AGM-R). The document length (10,347 characters) supports that it is a substantive report of the meeting proceedings, not a brief announcement or certification.
2025-09-29 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the closure of the trading window pursuant to SEBI regulations ahead of the announcement of unaudited financial results for the quarter and half year ended September 30, 2025. It does not contain any financial data or results itself, nor does it include a report or detailed financial statements. It is an announcement related to compliance and insider trading restrictions before the release of an interim financial report. The document length is short (1578 characters) and it serves as a notification rather than a report. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2025-09-26 English
Intimation of closure of Trading Window for the quarter and half year ended September 30, 2025 is attached herewith.
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about the closure of the trading window in compliance with SEBI regulations related to insider trading. It mentions the upcoming declaration of unaudited financial results for the quarter and half year ended September 30, 2025, but does not contain any financial data or the results themselves. The document is short (1578 characters) and serves as an announcement or intimation rather than a report. Therefore, it fits the category of a Regulatory Filing (RNS) as it is a compliance-related announcement that does not contain substantive financial information or the actual financial report.
2025-09-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.